Skip to content
Screener

Passage Bio, Inc. PASG Q2 2026 earnings

Reported August 10, 2026 · Before market open

EPS-$2.44In line
EPS estimate-$2.44

Next report

Nov 9, 2026 (in 2 months)
EPS estimate-$2.44

FAQ

When did Passage Bio, Inc. report Q2 2026 earnings?
Passage Bio, Inc. (PASG) reported Q2 2026 earnings on August 10, 2026 before market open.
What were Passage Bio, Inc.'s Q2 2026 revenue and EPS?
Passage Bio, Inc. reported eps of $-2.44 for Q2 2026.
Did Passage Bio, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-2.44 by $0.00.
How did Passage Bio, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 17.6% from $-2.96.
Where can I find Passage Bio, Inc.'s Q2 2026 SEC filings?
You can read the 10-Q periodic report (0001104659-26-093021) directly on SEC EDGAR. The filing index links above go to sec.gov.